✦ LIBER ✦

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

✍ Scribed by Van Poznak, C.H.; Brown, J.E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pamidronate in the Prevention of Chemoth

✍ Van Poznak, C.H. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Pamidronate in the Prevention of Chemoth

✍ Fuleihan, Ghada El-Hajj; Salamoun, Mariana; Mourad, Yasser Abou; Chehal, Aref; S 📂 Article 📅 2005 🏛 Endocrine Society 🌐 English ⚖ 126 KB

Risedronate for prevention of bone miner

✍ C. C. Mok; K. H. Tong; C. H. To; Y. P. Siu; K. M. Ma 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Randomized, Double-Blinded, Placebo-Cont

✍ Choo, Richard; Lukka, Himu; Cheung, Patrick; Corbett, Tom; Briones-Urbina, Rosar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Zoledronic acid prevents bone loss in pr

✍ Jeong Eun Kim; Jin-Hee Ahn; Kyung Hae Jung; Sung-Bae Kim; Hwa Jung Kim; Keun-Suk 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 356 KB

A randomised, placebo-controlled, double

✍ Helen G. Mar Fan; Mark Clemons; Wei Xu; Irene Chemerynsky; Henriette Breunis; Sh 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 139 KB